DNB Asset Management AS Has $138.61 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

DNB Asset Management AS lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 244,742 shares of the medical equipment provider’s stock after selling 5,119 shares during the quarter. DNB Asset Management AS’s holdings in Intuitive Surgical were worth $138,612,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Newbridge Financial Services Group Inc. raised its position in Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 33 shares during the last quarter. Holos Integrated Wealth LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $25,000. Olistico Wealth LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $28,000. Laurel Wealth Advisors LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $31,000. Finally, Turning Point Benefit Group Inc. boosted its holdings in Intuitive Surgical by 833.3% during the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 50 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, SVP Mark Brosius sold 645 shares of the firm’s stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the completion of the sale, the senior vice president directly owned 1,613 shares of the company’s stock, valued at $782,321.13. This trade represents a 28.57% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $446.95, for a total value of $178,780.00. Following the completion of the sale, the executive vice president directly owned 6,120 shares of the company’s stock, valued at approximately $2,735,334. The trade was a 6.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 5,647 shares of company stock valued at $2,760,359. Insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently commented on ISRG shares. Raymond James Financial reduced their target price on shares of Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a report on Wednesday, April 22nd. Zacks Research cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 30th. UBS Group reduced their target price on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a report on Tuesday, March 17th. Piper Sandler reduced their target price on shares of Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Finally, Truist Financial reduced their price target on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research report on Wednesday, April 15th. Eighteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $581.91.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Multiple recent articles highlighted Intuitive Surgical as a potential beneficiary of the AI boom in healthcare, arguing that every robotic procedure creates valuable data that can improve surgeon training, intraoperative guidance, and predictive analytics. Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom
• Positive Sentiment: Analysts at Erste Group Bank nudged up their FY2026 and FY2027 earnings estimates for ISRG, reinforcing expectations that earnings growth can continue above consensus. MarketBeat ISRG coverage
• Positive Sentiment: Coverage around da Vinci 5 pointed to strong procedure growth and higher system utilization, suggesting the company’s newest platform is still gaining traction with surgeons and hospitals. Can ISRG’s da Vinci 5 Momentum Sustain Procedure and Utilization Gains?
• Neutral Sentiment: Several bullish opinion pieces said the recent selloff has made Intuitive Surgical look more attractive to growth investors, but these were mostly commentary rather than new company-specific catalysts. Intuitive Surgical Has Dropped 20% This Year. Wall Street Says It’s Time to Buy.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $421.12 on Friday. The stock has a 50 day moving average price of $463.63 and a 200 day moving average price of $514.04. Intuitive Surgical, Inc. has a 52 week low of $417.74 and a 52 week high of $603.88. The stock has a market capitalization of $149.14 billion, a PE ratio of 51.04, a price-to-earnings-growth ratio of 3.42 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same period in the prior year, the firm posted $1.81 earnings per share. The business’s quarterly revenue was up 23.0% compared to the same quarter last year. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.